SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-07-002908
Filing Date
2007-05-07
Accepted
2007-05-07 16:37:31
Documents
7
Period of Report
2007-03-31

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b65122oie10vq.htm 10-Q 207845
2 EX-10.1 EMPLOYMENT AGREEMENT-JOHN KOLLINS b65122oiexv10w1.txt EX-10.1 34029
3 EX-10.2 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT-DAVID CHAPLIN b65122oiexv10w2.txt EX-10.2 4748
4 EX-10.3 SEPARATION AGREEMENT-SCOTT YOUNG b65122oiexv10w3.txt EX-10.3 26994
5 EX-31.1 SECTION 302 CERTIFICATION OF CEO b65122oiexv31w1.htm EX-31.1 6136
6 EX-31.2 SECTION 302 CERTIFICATION OF CFO b65122oiexv31w2.htm EX-31.2 6173
7 EX-32.1 SECTION 906 CERTIFICATION OF CEO & CFO b65122oiexv32w1.htm EX-32.1 4278
  Complete submission text file 0000950135-07-002908.txt   291498
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 07824455
SIC: 2836 Biological Products, (No Diagnostic Substances)